RxDoctor Payments Data

Sarah Mueller

Psychiatric/Mental Health · Fredericktown, MONPI 1851025696

Payments from drug & device makers

$2,169in general payments, 2019–2025

Across 127 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$560
  • AbbVie$401
  • Otsuka America Pharmaceutical, Inc.$327
  • Vanda Pharmaceuticals Inc.$135
  • Johnson & Johnson$129
  • Neurocrine Biosciences, Inc.$129
  • plus $488 from 6 others

What the payments were for

  • Food & beverage$2,15099%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,169 in reported general payments places this provider in the 70th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$16,541
Medicare patients
51
Services billed
205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate54$169,735
RexultiBrexpiprazole58$84,060
CaplytaLumateperone Tosylate25$40,879
VraylarCariprazine Hcl29$37,380
Abilify MaintenaAripiprazole11$30,519
VivitrolNaltrexone Microspheres12$19,375
Lurasidone Hcl102$8,701
FetzimaLevomilnacipran Hcl11$8,312
TrintellixVortioxetine Hydrobromide13$6,415
Desvenlafaxine Succinate ErDesvenlafaxine Succinate57$4,197
Paliperidone ErPaliperidone46$3,688
Aripiprazole80$2,738
Venlafaxine Hcl ErVenlafaxine Hcl158$2,297
Quetiapine Fumarate242$2,265
Bupropion XlBupropion Hcl183$2,174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$129$169,73554 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$327$114,57969 claims
AbbVieVraylar, Fetzima$401$45,69240 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$560$40,87925 claims
Alkermes, Inc.Vivitrol$94$19,37512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Fredericktown

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →